Kim Brøsen

Citado por

	Total	Desde 2019
Citas	20744	3310
Índice h	83	29
Índice i10	226	94

820

410

205

615

19891990199119921993199419951996199719981999200020012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023202487 101 125 204 333 326 361 506 539 560 613 606 663 640 736 805 738 765 730 692 815 668 676 671 749 648 705 687 581 661 641 619 595 590 481 380

Acceso público

Ver todo

28 artículos

6 artículos

disponibles

no disponibles

Basado en requisitos de financiación

Coautores

Per DamkierDirección de correo verificada de health.sdu.dk
Tore B. StageProfessor, Translational Pharmacology, University of Southern DenmarkDirección de correo verificada de health.sdu.dk
Troels K BergmannAssociate professor, University of Southern Denmark, Odense, DenmarkDirección de correo verificada de rsyd.dk
Lars Arendt-NielsenDirector, professor, dr med sci, ph dDirección de correo verificada de hst.aau.dk
Jesper HallasUniversity of Southern DenmarkDirección de correo verificada de health.sdu.dk
Henrik E. PoulsenProfessor Klinisk FarmakologiDirección de correo verificada de rh.dk
Steffen LoftUniversity of Copenhagen, Department of Public HealthDirección de correo verificada de sund.ku.dk
Henrik GreenLinköping University Dirección de correo verificada de liu.se
Niels JessenProfessor of Clinical Pharmacology, Aarhus UniversitetDirección de correo verificada de clin.au.dk
Troels Staehelin JensenProfessor of Neurology, Aarhus UniversityDirección de correo verificada de clin.au.dk
Werner VachSenior Researcher in Applied Methodology, Basel Academy for Quality and Research in MedicineDirección de correo verificada de crossklinik.ch
Mansoor Raza MirzaNordic Society of Gynaecological Oncology & Rigshospitalet, Copenhagen, DenmarkDirección de correo verificada de regionh.dk
Søren Mikkelsen, Professor, MD PhDPrehospital Research Unit, the Region of Southern Denmark, Odense University Hospital, DenmarkDirección de correo verificada de rsyd.dk
Jorgen FrokiaerProfessor i medicin, Aarhus UniversitetDirección de correo verificada de ki.au.dk
Mogens HorderUniversity of Southern DenamrkDirección de correo verificada de health.sdu.dk
Lars Christian GormsenLektor, overlæge, Aarhus UniversitetshospitalDirección de correo verificada de rm.dk
Peter BjerringProfessor, Department of Dermatology, Aalborg University HospitalDirección de correo verificada de peterbjerring.dk
Anton PottegårdProfessor, University of Southern DenmarkDirección de correo verificada de health.sdu.dk
Kim BrixenMedical Director, Odense University HospitalDirección de correo verificada de rsyd.dk
Ivar S KristiansenProfessor of community medicine University of OsloDirección de correo verificada de medisin.uio.no

Seguir

Kim Brøsen

Professor in Clinical Pharmacology, University of Southern Denmark

Dirección de correo verificada de health.sdu.dk - Página principal

Pharmacogenetics drug metabolism dry-drug interactions pharmacogenetics


Título Ordenar por citas Ordenar por año Ordenar por título	Citado por Citado por	Año
The selective serotonin reuptake inhibitor paroxetine is effective in the treatment of diabetic neuropathy symptoms SH Sindrup, LF Gram, K Brøsen, O Eshøj, EF Mogensen Pain 42 (2), 135-144, 1990	640	1990
CYP2D6 and CYP2C19 genotype‐based dose recommendations for antidepressants: a first step towards subpopulation‐specific dosages J Kirchheiner, K Brøsen, ML Dahl, LF Gram, S Kasper, I Roots, F Sjöqvist, ... Acta Psychiatrica Scandinavica 104 (3), 173-192, 2001	571	2001
Paroxetine: a selective serotonin reuptake inhibitor showing better tolerance, but weaker antidepressant effect than clomipramine in a controlled multicenter study Danish University Antidepressant Group Journal of Affective Disorders 18 (4), 289-299, 1990	563	1990
The hypoalgesic effect of tramadol in relation to CYP2D6 L Poulsen, L Arendt‐Nielsen, K Brøsen, SH Sindrup Clinical Pharmacology & Therapeutics 60 (6), 636-644, 1996	492	1996
Tramadol relieves pain and allodynia in polyneuropathy: a randomised, double-blind, controlled trial SH Sindrup, G Andersen, C Madsen, T Smith, K Brøsen, TS Jensen Pain 83 (1), 85-90, 1999	482	1999
Drug related hospital admissions: the role of definitions and intensity of data collection, and the possibility of prevention J Hallas, B Harvald, LF Gram, E Grodum, K Brøsen, T Haghfelt, N Damsbo Journal of internal medicine 228 (2), 83-90, 1990	479	1990
Fluvoxamine is a potent inhibitor of cytochrome P4501A2 K Brøsen, E Skjelbo, BB Rasmussen, HE Poulsen, S Loft Biochemical pharmacology 45 (6), 1211-1214, 1993	444	1993
Dose-dependent inhibition of CYP1A2, CYP2C19 and CYP2D6 by citalopram, fluoxetine, fluvoxamine and paroxetine U Jeppesen, LF Gram, K Vistisen, S Loft, HE Poulsen, K Brøsen European journal of clinical pharmacology 51, 73-78, 1996	427	1996
The selective serotonin reuptake inhibitor citalopram relieves the symptoms of diabetic neuropathy SH Sindrup, U Bjerre, A Dejgaard, K Brøsen, T Aaes‐Jørgensen, LF Gram Clinical Pharmacology & Therapeutics 52 (5), 547-552, 1992	391	1992
Clinical significance of the sparteine/debrisoquine oxidation polymorphism K Brøsen, LF Gram European Journal of Clinical Pharmacology 36, 537-547, 1989	380	1989
Drug related admissions to medical wards: a population based survey. J Hallas, LF Gram, E Grodum, N Damsbo, K Brosen, T Haghfelt, B Harvald, ... British journal of clinical pharmacology 33 (1), 61-68, 1992	314	1992
Codeine and morphine in extensive and poor metabolizers of sparteine: pharmacokinetics, analgesic effect and side effects L Poulsen, K Brøsen, L Arendt-Nielsen, LF Gram, K Elbaek, SH Sindrup European journal of clinical pharmacology 51, 289-295, 1996	313	1996
The pharmacogenetics of metformin and its impact on plasma metformin steady-state levels and glycosylated hemoglobin A1c MMH Christensen, C Brasch-Andersen, H Green, F Nielsen, P Damkier, ... Pharmacogenetics and genomics 21 (12), 837-850, 2011	308	2011
The interindividual differences in the 3-demthylation of caffeine alias CYP1A2 is determined by both genetic and environmental factors BB Rasmussen, TH Brix, KO Kyvik, K Brøsen Pharmacogenetics and Genomics 12 (6), 473-478, 2002	285	2002
Pharmacokinetics of citalopram in relation to the sparteine and the mephenytoin oxidation polymorphisms SH Sindrup, K Brøsen, MGJ Hansen, T Aaes-Jørgensen, KF Overø, ... Therapeutic drug monitoring 15 (1), 11-17, 1993	277	1993
The relationship between paroxetine and the sparteine oxidation polymorphism SH Sindrup, K Brøsen, LF Gram, J Hallas, E Skjelbo, A Allen, GD Allen, ... Clinical Pharmacology & Therapeutics 51 (3), 278-287, 1992	258	1992
The pharmacogenetics of codeine hypoalgesia SH Sindrup, K Brøsen Pharmacogenetics and Genomics 5 (6), 335-346, 1995	253	1995
Recent developments in hepatic drug oxidation implications for clinical pharmacokinetics K Brosen Clinical pharmacokinetics 18, 220-239, 1990	250	1990
Inhibition by paroxetine of desipramine metabolism in extensive but not in poor metabolizers of sparteine K Brøsen, JG Hansen, KK Nielsen, SH Sindrup, LF Gram European journal of clinical pharmacology 44, 349-355, 1993	238	1993
Inhibitors of imipramine metabolism by human liver microsomes. E Skjelbo, K Brosen British journal of clinical pharmacology 34 (3), 256-261, 1992	218	1992

El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.

Artículos 1–20

Citas por año

Citas duplicadas

Citas combinadas

Añadir coautoresCoautores

Seguir

Citado por

Coautores